Spots Global Cancer Trial Database for squamous cell
Every month we try and update this database with for squamous cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. | NCT01652469 | Carcinoma, Non-... | Erlotinib Docetaxel | 18 Years - | ETOP IBCSG Partners Foundation | |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma | NCT03336606 | Head and Neck C... Head and Neck S... Melanoma Cell Cancer, Sq... Carcinoma, Squa... | MEDI0562 | 18 Years - | Providence Health & Services | |
| Study of TVEC in Patients With Cutaneous Squamous Cell Cancer | NCT03714828 | Squamous Cell C... Skin Cancer Keratoacanthoma Cutaneous Tumor Skin Cancer, Sq... Lesion Skin | Injection of TV... Injection of TV... Injection of TV... Injection of TV... | 18 Years - | University of Arizona | |
| Pembrolizumab in Combination With CRT for LA-SCCHN | NCT02586207 | Head and Neck C... Squamous Cell C... Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer Laryngeal Cance... | pembrolizumab (... Cisplatin Radiation | 18 Years - | Sanford Health | |
| Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer | NCT00735904 | Carcinoma, Non-... | AG-013736 gemcitabine cisplatin | 18 Years - | Pfizer | |
| Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers | NCT02994069 | Carcinoma, Squa... Head and Neck C... | Cisplatin XRT | 18 Years - | University of Kentucky | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer | NCT00176267 | Squamous Cell C... | Radiotherapy Paclitaxel Carboplatin | 18 Years - | University of Kentucky | |
| Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer | NCT00735904 | Carcinoma, Non-... | AG-013736 gemcitabine cisplatin | 18 Years - | Pfizer | |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma | NCT03336606 | Head and Neck C... Head and Neck S... Melanoma Cell Cancer, Sq... Carcinoma, Squa... | MEDI0562 | 18 Years - | Providence Health & Services | |
| Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer | NCT01161498 | Squamous Cell C... Head and Neck C... | Talimogene Lahe... Radiation Cisplatin | 18 Years - | BioVex Limited | |
| Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC) | NCT00832715 | Lung Cancer | EBUS-TBNA | 18 Years - | M.D. Anderson Cancer Center | |
| A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN) | NCT01080066 | Carcinoma, Squa... | No Intervention | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01412229 | Head and Neck C... | Cetuximab Nab-paclitaxel Carboplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Laparoscopic Approach to Cervical Cancer | NCT00614211 | Cervical Cancer | Total Abdominal... Total Laparosco... | 18 Years - | Queensland Centre for Gynaecological Cancer | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck | NCT01275183 | Head and Neck C... | raltegravir and... | 18 Years - | New Mexico Cancer Care Alliance | |
| Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) | NCT01416961 | Lung Cancer | Radiation Thera... Chemotherapy - ... Chemotherapy - ... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Phase II Trial of Allovectin-7® for Head and Neck Cancer | NCT00050388 | Head and Neck C... Squamous Cell C... Head and Neck N... Carcinoma of th... | Allovectin-7® | 18 Years - | Vical | |
| Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. | NCT01652469 | Carcinoma, Non-... | Erlotinib Docetaxel | 18 Years - | ETOP IBCSG Partners Foundation | |
| Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC | NCT00252382 | Carcinoma, Non-... | SNS-595 Injecti... | 18 Years - | Sunesis Pharmaceuticals | |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01412229 | Head and Neck C... | Cetuximab Nab-paclitaxel Carboplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer | NCT01326923 | Head and Neck S... | Cetuximab | 18 Years - | Louisiana State University Health Sciences Center Shreveport | |
| A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | NCT00998192 | Metastatic or R... | REOLYSIN Paclitaxel Carboplatin | 18 Years - | Oncolytics Biotech | |
| Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | NCT03370406 | Carcinoma, Squa... | 5-fluorouracil Imiquimod 5% cr... | 18 Years - | University of Pittsburgh | |
| Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer | NCT00176267 | Squamous Cell C... | Radiotherapy Paclitaxel Carboplatin | 18 Years - | University of Kentucky | |
| Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma | NCT01855451 | HPV Positive Or... | Cetuximab RT (70 Gy in 35... Cisplatin | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin | NCT02883556 | Carcinoma, Squa... | Pembrolizumab | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer | NCT01161498 | Squamous Cell C... Head and Neck C... | Talimogene Lahe... Radiation Cisplatin | 18 Years - | BioVex Limited | |
| Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma | NCT01855451 | HPV Positive Or... | Cetuximab RT (70 Gy in 35... Cisplatin | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck | NCT00519077 | Head and Neck N... | Gefitinib | 18 Years - | University of Chicago | |
| Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix | NCT00204997 | Cervical Cancer | Laparoscopic ov... | 18 Years - 40 Years | University of Wisconsin, Madison | |
| Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer | NCT00176254 | Squamous Cell C... | Radiotherapy Paclitaxel Carboplatin | 18 Years - | University of Kentucky | |
| Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. | NCT01652469 | Carcinoma, Non-... | Erlotinib Docetaxel | 18 Years - | ETOP IBCSG Partners Foundation | |
| A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung | NCT00998192 | Metastatic or R... | REOLYSIN Paclitaxel Carboplatin | 18 Years - | Oncolytics Biotech | |
| Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | NCT03370406 | Carcinoma, Squa... | 5-fluorouracil Imiquimod 5% cr... | 18 Years - | University of Pittsburgh | |
| Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 | NCT00743353 | Sarcoma Melanoma Lung Cancer Breast Cancer High Grade Glio... | F-18 RGD-K5 | 18 Days - | Siemens Molecular Imaging | |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT01412229 | Head and Neck C... | Cetuximab Nab-paclitaxel Carboplatin | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma | NCT00753038 | Carcinoma, Squa... | REOLYSIN® Carboplatin Paclitaxel | 18 Years - | Oncolytics Biotech | |
| Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer | NCT00735904 | Carcinoma, Non-... | AG-013736 gemcitabine cisplatin | 18 Years - | Pfizer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
